Gotowa bibliografia na temat „Macrophage inhibitory cytokine”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Macrophage inhibitory cytokine”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Macrophage inhibitory cytokine"
Colon-Echevarria, Claudia B., Tatiana Ortiz, Lizette Maldonado, Melanie J. Hidalgo-Vargas, Jaileene Pérez-Morales, Alexandra N. Aquino-Acevedo, Roberto Herrera-Noriega, Margarita Bonilla-Claudio, Eida M. Castro i Guillermo N. Armaiz-Pena. "Zoledronic Acid Abrogates Restraint Stress-Induced Macrophage Infiltration, PDGF-AA Expression, and Ovarian Cancer Growth". Cancers 12, nr 9 (18.09.2020): 2671. http://dx.doi.org/10.3390/cancers12092671.
Pełny tekst źródłaLu, Chunxia, P. Anil Kumar, Yong Fan, Mark A. Sperling i Ram K. Menon. "A Novel Effect of Growth Hormone on Macrophage Modulates Macrophage-Dependent Adipocyte Differentiation". Endocrinology 151, nr 5 (25.02.2010): 2189–99. http://dx.doi.org/10.1210/en.2009-1194.
Pełny tekst źródłaBorsini, Alessandra, Maria Grazia Di Benedetto, Juliette Giacobbe i Carmine M. Pariante. "Pro- and Anti-Inflammatory Properties of Interleukin in Vitro: Relevance for Major Depression and Human Hippocampal Neurogenesis". International Journal of Neuropsychopharmacology 23, nr 11 (29.07.2020): 738–50. http://dx.doi.org/10.1093/ijnp/pyaa055.
Pełny tekst źródłaKasama, Tsuyoshi, Kumiko Ohtsuka, Michihito Sato, Ryo Takahashi, Kuninobu Wakabayashi i Kazuo Kobayashi. "Macrophage Migration Inhibitory Factor: A Multifunctional Cytokine in Rheumatic Diseases". Arthritis 2010 (3.01.2010): 1–10. http://dx.doi.org/10.1155/2010/106202.
Pełny tekst źródłaHuh, Sung Jin, Chin-Ying Chung, Arati Sharma i Gavin P. Robertson. "Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development". American Journal of Pathology 176, nr 6 (czerwiec 2010): 2948–57. http://dx.doi.org/10.2353/ajpath.2010.090963.
Pełny tekst źródłaCalandra, T., J. Bernhagen, R. A. Mitchell i R. Bucala. "The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor." Journal of Experimental Medicine 179, nr 6 (1.06.1994): 1895–902. http://dx.doi.org/10.1084/jem.179.6.1895.
Pełny tekst źródłaBaer, Mark, Allan Dillner, Richard C. Schwartz, Constance Sedon, Sergei Nedospasov i Peter F. Johnson. "Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50". Molecular and Cellular Biology 18, nr 10 (1.10.1998): 5678–89. http://dx.doi.org/10.1128/mcb.18.10.5678.
Pełny tekst źródłaBozza, Marcelo T., Yuri C. Martins, Letícia A. M. Carneiro i Claudia N. Paiva. "Macrophage Migration Inhibitory Factor in Protozoan Infections". Journal of Parasitology Research 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/413052.
Pełny tekst źródłaNishi, Kosuke, Takako Ito, Ayumu Kadota, Momoko Ishida, Hisashi Nishiwaki, Naohiro Fukuda, Naoaki Kanamoto, Yoko Nagata i Takuya Sugahara. "Aqueous Extract from Leaves of Citrus unshiu Attenuates Lipopolysaccharide-Induced Inflammatory Responses in a Mouse Model of Systemic Inflammation". Plants 10, nr 8 (19.08.2021): 1708. http://dx.doi.org/10.3390/plants10081708.
Pełny tekst źródłaLemay, Serge, Tatiana V. Lebedeva i Ajay K. Singh. "Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism". Clinical Diagnostic Laboratory Immunology 6, nr 4 (1.07.1999): 567–72. http://dx.doi.org/10.1128/cdli.6.4.567-572.1999.
Pełny tekst źródłaRozprawy doktorskie na temat "Macrophage inhibitory cytokine"
Patrikainen, Lila. "Prostatic gene expression : probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes /". Oulu : Oulun yliopisto, 2004. http://herkules.oulu.fi/isbn9514272730/.
Pełny tekst źródłaPatrikainen, L. (Lila). "Prostatic gene expression: probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes". Doctoral thesis, University of Oulu, 2004. http://urn.fi/urn:isbn:9514272730.
Pełny tekst źródłaPowell, Nicole Damico. "Immunomodulation of experimental autoimmune encephalomyelitis targeting the autoreactive T cell and the cytokine macrophage migration inhibitory factor /". Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1141052089.
Pełny tekst źródłaNguyen, Tuyet Mai. "Elucidation of thiol-protein oxidoreductase activity of the cytokine macrophage migration inhibitory factor (MIF) by biochemical redox and site-specific mutagenesis analysis". [S.l. : s.n.], 2003. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB10520514.
Pełny tekst źródłaBaeza, Garcia Alvaro. "Rôle de MIF (Macrophage Migration Inhibitory Factor) dans l'immunité innée et la réponse anti-schistosome chez Biomphalaria glabrata". Phd thesis, Université du Droit et de la Santé - Lille II, 2010. http://tel.archives-ouvertes.fr/tel-00665113.
Pełny tekst źródłaBaía, Diogo Nogueira de Graça 1984. "Role of the LILRB1 HLA class I-specific inhibitory receptor in the regulation of macrophage function". Doctoral thesis, Universitat Pompeu Fabra, 2014. http://hdl.handle.net/10803/380898.
Pełny tekst źródłaEn aquest projecte hem analitzat la participació del receptor inhibidor específic per HLA de classe I: LILRB1, en la regulació de la funció dels macròfags humans (MΦ). Els macròfags M1 i M2 diferenciats in vitro expressen nivells diferents de LILRB1. Aportem evidències experimentals que recolzen el paper de la interacció LILRB1/HLA-I com element regulador del llindar d’activació en la homeòstasi del macròfag, influint en la secreció de citocines en condicions basals així com en resposta a cèl.lules tumorals i a la senyalització de receptors activadors dependents de motius ITAM. D’altra banda, les nostres observacions indiquen que el reconeixement de cèl.lules diana per part de LILRB1 es dóna independentment del nivell d’expressió de les molècules del HLA en la seva superfície, però correlaciona amb la dimerització d’aquestes molècules. Aquest canvi conformacional, detectat en MΦ tractats amb interferons de tipus I, s’associa a un increment de la interacció entre LILRB1 i HLA-I, suggerint un possible mecanisme regulador de l’activació del MΦ.
Rasiah, Krishan Kumar St Vincent's UNSW. "The identification of novel biomarkers in the development and progression of early prostate cancer". Awarded by:University of New South Wales. St Vincent's, 2006. http://handle.unsw.edu.au/1959.4/24187.
Pełny tekst źródłaLacey, Derek. "NFκB independent pathway activation of rheumatoid arthritis FLS by macrophage migration inhibitory factor (MIF)". Monash University, Faculty of Medicine, 2003. http://arrow.monash.edu.au/hdl/1959.1/9457.
Pełny tekst źródłaLo, Wing-sze, i 盧詠詩. "The role of macrophage migration inhibitory factor in the pathogenesisof acute graft-versus-host disease following allogeneic bone marrowtransplantation". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2001. http://hub.hku.hk/bib/B31226413.
Pełny tekst źródłaMichelet, Claire. "Analyse évolutive et fonctionnelle des Macrophage Migration Inhibitory Factors chez les eucaryotes". Thesis, Université Côte d'Azur (ComUE), 2018. http://www.theses.fr/2018AZUR4109/document.
Pełny tekst źródłaMacrophage migration inhibitory factors (MIF) are multifunctional proteins regulating major processes in mammals, including control of the cell cycle and migration, activation of innate immune responses, and prevention of p53-mediated apoptosis. MIF proteins also play a role in innate immunity of invertebrate organisms or serve as virulence factors in parasitic organisms, raising the question of their evolutionary history and of a putative differential evolution of structure/function relationships. The general aim of this PhD was to explore the diversity and evolutionary history of MIF proteins accross kingdoms, and to investigate their potential functional differences, with a special emphasis on host-parasite systems. We first performed a broad survey of MIF presence or absence and evolutionary relationships across 803 species of plants, fungi, protists, and animals, and explored a potential relation with the taxonomic status, the ecology, and the lifestyle of individual species. We show that MIF evolutionary history in eukaryotes is complex, involving ancestral duplications, multiple gene losses and recent clade-specific re-duplications. Of note, plants and plant parasites (other than fungi) harbour a median number of three MIFs, while heterotrophic and animal parasite species harbour a lower or/and variable MIF number. Intriguingly, MIFs seem to be essential and highly conserved with many sites under purifying selection in some kingdoms (e.g. plants), while in other kingdoms they appear more dispensable (e.g. in fungi) or present in several diverged variants (e.g. insects, nematodes), suggesting potential neofunctionalizations within the protein superfamily. We then analysed the effect of MIF proteins from selected species on plant cell death. All organisms tested (plant, oomycetes, protozoa, insects, and nematodes) including species that are not in interaction with plants, possess at least one MIF protein showing a significant cell death inhibitory effect. This suggests that plant cell death inhibition does not result from a neofunctionalization of MIF from plant-parasites, and is related to conserved structural features of MIF proteins. However, none of the parameters predicted in silico (sequence motifs, 3D structures, oligomerization, post-traductional modifications) appeared to be related to the cell death inhibitory activity. Future extensive functional studies are necessary to unravel the structure-function relationship of these evolutionarily and functionally complex proteins
Książki na temat "Macrophage inhibitory cytokine"
Bucala, Richard. Mif Handbook. World Scientific Publishing Co Pte Ltd, 2012.
Znajdź pełny tekst źródłaFleischmann, Roy. Signalling pathway inhibitors. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081.
Pełny tekst źródłaBerry, Martin, i Ann Logan. CNS Injuries: Cellular Responses and Pharmacological Strategies (Pharmacology & Toxicology (Crc Pr)). CRC, 1998.
Znajdź pełny tekst źródłaM, Berry, i Logan Ann, red. CNS injuries: Cellular responses and pharmacological strategies. Boca Raton: CRC Press, 1999.
Znajdź pełny tekst źródłaCzęści książek na temat "Macrophage inhibitory cytokine"
Feng, Lili, Byeong C. Jang i Daniel Hwang. "Inhibitor of Protein Tyrosine Kinase, Radicicol, Suprresses the Expression of Cyclooxygenase and Pro-Inflammatory Cytokines in LPS-Stimulated Rat Alveolar Macrophage in Part by Accelerating Degradation of mRNA". W Advances in Experimental Medicine and Biology, 281–88. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-1813-0_42.
Pełny tekst źródła"Macrophage Inhibitory Cytokine 1". W Encyclopedia of Cancer, 2609. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_101405.
Pełny tekst źródłaARENBERG, D., i R. BUCALA. "Macrophage migration inhibitory factor (MIF)". W The Cytokine Handbook, 1037–48. Elsevier, 2003. http://dx.doi.org/10.1016/b978-012689663-3/50049-1.
Pełny tekst źródła"Macrophage Migration Inhibitory Factor (MIF )". W Cytokine Gene Polymorphisms in Multifactorial Conditions, 219–34. CRC Press, 2006. http://dx.doi.org/10.1201/9781420005325-22.
Pełny tekst źródłaAlourfi, Zaynab, David Ray i Rachelle Donn. "Macrophage Migration Inhibitory Factor (MIF)". W Cytokine Gene Polymorphisms in Multifactorial Conditions, 191–205. CRC Press, 2006. http://dx.doi.org/10.1201/9781420005325.ch14.
Pełny tekst źródłaFleischmann, Roy. "Signalling pathway inhibitors". W Oxford Textbook of Rheumatology, 630–35. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081_update_003.
Pełny tekst źródłaCheng, Jianguo. "Mechanisms of Neuropathic Pain". W Neuropathic Pain, redaktor Jianguo Cheng, 17–26. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190298357.003.0003.
Pełny tekst źródła"Eicosanoid Inhibitor and Cytokine Regulation of 1,25(OH)2D3 Synthesis in Synovial Fluid Macrophages from Patients with Inflammatory Arthritis". W Vitamin D, 145–46. De Gruyter, 1994. http://dx.doi.org/10.1515/9783110882513-051.
Pełny tekst źródłaStreszczenia konferencji na temat "Macrophage inhibitory cytokine"
Karan, Dev, Seema Dubey, Jo Wick, Ossama Tawfik, Guru Sonpavde i Peter VanVeldhuizen. "Abstract B12: Macrophage inhibitory cytokine-1 as a potential biomarker for racial disparity in prostate cancer". W Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-b12.
Pełny tekst źródłaJin, Young-June, Jeong-Hyung Lee, Young-Myeong Kim, Keun-Cheol Kim i Hansoo Lee. "Abstract 3041: Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating Cyclins D1 and E through the PI3K/Akt- and ERK-dependent AP-1 and E2F activation signaling pathways". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3041.
Pełny tekst źródłaSegal, Leopoldo, Rohan Kulkarni, Yoko Fujita, Anna Nolan, William N. Rom i Michael Weiden. "Azithromycin Suppresses Inflammatory Cytokines And Induces Inhibitory Transcription Factors In Alveolar Macrophages". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2853.
Pełny tekst źródłaLin, E., F. Vincent, J. Harris, R. Kandane-Rathnayake, G. S. Ngian, J. Sahhar, E. Morand i T. Lang. "THU0403 Serum levels of macrophage migration inhibitory factor and interleukin-1 family cytokines are elevated in systemic sclerosis". W Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3272.
Pełny tekst źródłaCharron, Catherine, Matthew Coates, Kazuhiro Ito, Chaitanya Vuppusetty, Masako To, John Murray, Peter Strong i Garth Rapeport. "Superior Effects Of RV1088, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Production In Macrophages". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4538.
Pełny tekst źródłaCharron, Catherine, Matthew Coates, Kazuhiro Ito, Chaitanya Vuppusetty, Masako To, John Murray, Peter Strong i Garth Rapeport. "Superior Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Roduction In Macrophages". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3088.
Pełny tekst źródłaChoudhary, Shilpa, James R. Pruitt, Thais M. Sielecki, Carol Pilbeam i John Arthur Taylor. "Abstract 159: Macrophage Migration Inhibitory Factor (MIF) enhances proliferation and expression of tumorigenic cytokines in a bladder cancer cell line". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-159.
Pełny tekst źródłaKaur, Manminder, Matthew Beardsall, Michael Salmon i Dave Singh. "GS-5759, A Novel Bi-Functional Phosphodiesterase 4 Inhibitor And Long-Acting ²2-Adrenoceptor Agonist Inhibits Cytokine Production From COPD Alveolar Macrophages". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5705.
Pełny tekst źródłaSpeth, J., L. R. K. Penke, J. D. Bazzill, J. J. Moon i M. Peters-Golden. "Synthetic Liposome Mimics of Alveolar Macrophage-Derived Vesicles Containing Suppressor of Cytokine Signaling 3: Inhibitors of Lung Tumor Cell Expansion and Potential Therapeutic for Lung Cancer". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7433.
Pełny tekst źródłaDres, Martin, Alexis Ferre, Amparo Buenestado, Stanislas Grassin Delyle, Emmanuel Naline, Nicolas Roche i Philippe Devillier. "Comparison Of A Cytokine Pattern Produced By Human Lung Macrophages And Pulmonary Parenchyma Explants In Response To Lipopolysaccharide And To A Cigarette Smoke Extract. Inhibitory Effect Of Budesonide". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2856.
Pełny tekst źródła